Ann: Application for quotation of securities - RLT, page-6

"DR DAVID KING REMUNERATION
Independent Non-executive Director Dr David King
was issued options on 1,000,000 shares of the
Company (or CDI equivalent) at the date of
completion of the initial public offering (IPO) with
a strike price equal to the IPO price plus a 20%
premium. The options will accrue to King annually
on completion of an entire year’s service on each
anniversary of his appointment at a rate of 250 000
shares per annum, including the fourth anniversary.
The options will mature at 250 000 shares per
annum on each anniversary of his appointment to
the Board. Thus, the shortest option will be one year
on 250 000 shares, and the most extended option
will be four years on 250 000 shares. Shareholders
approved this at the Annual General Meeting held
on Tuesday, 19 March 2019."

From the company Renumeration report"